25/11/2021 - Institutional news
The emeritus head of both the Pneumology Service at Hospital del Mar and the Myogenesis, Inflammation and Muscle Function research group at the Hospital del Mar Medical Research Institute is one of the fourteen experts invited to participate. Dr. Joaquim Gea, emeritus head of both the Pneumology service at Hospital del Mar and the Myogenesis, Inflammation and Muscle Function research group at the Hospital del Mar Medical Research Institute (IMM), was one of the two international experts, and the only European, invited to participate in the drafting of the consensus document for the Colombian Association of Pneumology and Thoracic Surgery, on the follow-up and treatment of patients who have overcome COVID-19.
17/11/2021 - Press release
Hospital del Mar, in collaboration with Roche, is working on a pioneering artificial intelligence tool to improve the diagnosis and prognosis of patients with small cell lung cancer, one of the cancers with the worst outlook. Based on digitised images from patient biopsies and survival data, the aim is to test whether the tool can reliably predict the benefit of the various treatments. This would allow more effective selection of the most appropriate type of treatment. At a later stage, the aim is to evaluate the specific mutations present in each tumour and to analyse whether digital imaging is capable of predicting these. Hospital del Mar, in collaboration with Roche, has initiated the development of a pioneering artificial intelligence device to improve the diagnosis and prognosis of patients suffering small cell lung cancer. This is one of the lung cancers with the worst prognosis and having such a reliable tool will allow medical teams to determine the best treatment for each type of patient.
Més informació "Artificial intelligence for selecting the best lung cancer treatment"
17/11/2021 - Institutional news
Stanford University has recently published an update of the list of the top 2% most widely cited scientists in different disciplines, the World's Top 2% Scientists. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 180,000 researchers from the more than 8 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account. Of the dozen researchers from the IMIM and Hospital del Mar who appear on the list, special mention should be made of Dr. Jordi Mestres, coordinator of the GRIB (IMIM/UPF) systems pharmacology research group, who is ranked number 1 in Catalonia, number 5 in Spain and 263rd in the world in the Medicinal and Biomolecular Chemistry subfield out of the 88,725 researchers in this area. The research carried out by Dr. Mestres is at the interface between chemistry and biology, where the current focus is on the development of biocheminformatics tools and databases, the topographic analysis of molecular surfaces and the design of protocols for virtual screening.
18/11/2021 - Press release
A study by researchers from Hospital del Mar, the Hospital del Mar Medical Research Institute and Hospital Son Espases, shows that the combination of a new antibiotic, ceftazidime/avibactam, with other antibiotics, can treat infections caused by variants of Pseudonomas aeruginosa that are resistant to all existing treatments. The study, published in Microbiology Spectrum, involved an in vitro analysis of the efficacy of the different treatments and their combinations to determine their effectiveness against variants of this bacterium, which is resistant to all existing drugs. Resistance to antibiotics has been identified by the World Health Organisation as one of the main threats to global health. Infection with Pseudomonas aeruginosa can cause pneumonia, heart problems and sepsis, especially in immunocompromised people
16/11/2021 - General information
Researchers from the Hospital del Mar Medical Research Institute and CIBERES detect an increase in oxidative stress in these patients that may favour tumour development. Reduced levels of the potent antioxidant glutathione may be used as a new early biomarker of cancer in people with chronic respiratory disease. The risk of developing lung cancer increases in patients with COPD (Chronic Obstructive Pulmonary Disease), so understanding the cellular mechanism involved in tumour progression is key. Indeed, researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the CIBER on Respiratory Diseases (CIBERES) have just published a study in the journal Biomedicines that identifies the role of systemic oxidative and antioxidant markers, which are differentially expressed in these patients with chronic respiratory diseases, and are therefore involved in the development of lung cancer.
Més informació "Lung cancer patients with COPD have worse disease progression"
11/11/2021 - General information
The AECC has awarded 186 grants in 2021, totalling approximately 20 million euros. Two of these will benefit IMIM researchers, Teresa Lobo, who is receiving a postdoctoral grant, and Arnau Sabater, who has been able to participate in the laboratory internship programme. The Spanish Association Against Cancer awarded its 2021 research grants at a ceremony held on 11 November at its headquarters in Barcelona. In total, 186 projects and nearly 20 million euros have been allocated with the aim of continuing progress into cancer research, focusing on the patient and further increasing cancer survival. In this edition, two researchers linked to the Hospital del Mar Medical Research Institute (IMIM) will benefit from the grants.
According to a study by the Hospital del Mar Medical Research Institute and the Germans Trias i Pujol Institute of Health Sciences published in the International Journal of Neuropsychopharmacology, driving after drinking alcohol mixed with energy drinks can give the driver a false sense of security, thus increasing the chances of driving while intoxicated and suffering an accident Due to their high caffeine content, energy drinks reduce the sedative effect of alcohol, despite not affecting its negative effects on driving ability Moreover, combining the two drinks increases blood concentrations of alcohol and caffeine. Researchers warn that these effects may favour alcohol intoxication in people with a lower tolerance to these drinks
Més informació "Mixing energy drinks with alcohol can increase the risk of a traffic accident"
Two projects by staff from the Hospital del Mar and the Hospital del Mar Medical Research Institute (IMIM) have been awarded funding by the Spanish Society of Medical Oncology as part of its 2021 grants. The awards were presented on 13 October in Madrid and represent a new record for the organisation, with 44 scholarships and grants awarded with an endowment of nearly 1.4 million euros. All the money is earmarked for research and the training of medical professionals to improve the survival and quality of life of cancer patients.
10/11/2021 - Institutional news
Five groups led by IMIM and Hospital del Mar professionals have been accepted as part of the new RICORS research networks. These Redes de Investigación Cooperativa Orientadas a Resultados en Salud, or Networks of Cooperative Research oriented to Health Results in English, are decided by the Instituto de Salud Carlos III and include funding, which in this case will be over €1.1 million. One of these groups will actually coordinate one of the RICORS networks. The aim of these new bodies is to promote research oriented towards health results by coordinating the research activity within the Spanish National Health System around a defined and focused research objective that is specifically useful for the general public, as well as structuring R&D&I in research groups from different Autonomous Communities, guiding their research activity towards common goals that enable results to be achieved which can then be transferred to the Spanish populace.
18/10/2021 - General information
These new grants are linked to the Spanish Government's Recovery, Transformation and Resilience Plan and are co-financed by the European Union's Next-Generation funds. Four projects involving the IMIM will benefit. Four research projects led by or involving researchers from the Hospital del Mar Medical Research Institute (IMIM) will receive funding from the State Research Agency (Agència Estatal d'Investigació), as part of the aid promoted in Spanish and European plans linked to recovery from the COVID-19 pandemic. In total of, each project will receive just over 790,000 euros from these funds.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
